Literature DB >> 7690353

Relationships among tenascin expression, DNA ploidy patterns, and multidrug resistance gene product (P-glycoprotein) in human colon carcinoma.

I Sugawara1, J Hirakoshi, M Kusakabe, A Masunaga, S Itoyama, T Sakakura.   

Abstract

Relationships among tenascin expression, DNA ploidy, and P-glycoprotein were examined in 81 primary human colon cancers and 61 metastatic lymph nodes. First, the DNA ploidy patterns of colon cancerous tissue surrounded (TN+) and not surrounded (TN-) by tenascin immunoreactivity were investigated. Then the expression of P-glycoprotein, one of two multidrug resistance gene products, was examined in TN+ and TN- colon cancer tissues by immunohistochemistry. Aneuploid DNA patterns were observed at high frequency in TN- colon cancer tissues (37/61) and metastatic lymph nodes (44/52). In contrast, diploid DNA patterns were observed predominantly in TN+ colon cancer tissues (50/56). Although P-glycoprotein expression was observed in primary TN+ and TN- colon cancer (9/81), the level of P-glycoprotein expression was not correlated with DNA aneuploidy in TN- colon cancer tissues. Overall, reduced tenascin expression was correlated well with DNA aneuploidy, but no significant correlation was found between DNA aneuploidy and P-glycoprotein appearing when cancer cells become resistant to several anti-cancer drugs. Thus, tenascin may play an important role in preventing colon cancer cells from invading surrounding tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690353      PMCID: PMC5919212          DOI: 10.1111/j.1349-7006.1993.tb02032.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  21 in total

1.  Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study?

Authors:  G I Meling; T O Rognum; O P Clausen; Y Chen; O C Lunde; E Schlichting; J N Wiig; J Hognestad; A Bakka; O Havig
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

2.  Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis.

Authors:  I Sugawara; J Hirakoshi; A Masunaga; S Itoyama; T Sakakura
Journal:  Invasion Metastasis       Date:  1991

3.  Two contrary functions of tenascin: dissection of the active sites by recombinant tenascin fragments.

Authors:  J Spring; K Beck; R Chiquet-Ehrismann
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

4.  Detection of bladder cancers using a SAMBA 200 cell image processor.

Authors:  G Brugal; C Quirion; P Vassilakos
Journal:  Anal Quant Cytol Histol       Date:  1986-09       Impact factor: 0.302

Review 5.  Multiple-drug resistance in human cancer.

Authors:  I Pastan; M Gottesman
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

6.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

7.  Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.

Authors:  E Georges; G Bradley; J Gariepy; V Ling
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 8.  What distinguishes tenascin from fibronectin?

Authors:  R Chiquet-Ehrismann
Journal:  FASEB J       Date:  1990-06       Impact factor: 5.191

Review 9.  Tenascin in tissue perturbation repair.

Authors:  T Sakakura; I Kusano
Journal:  Acta Pathol Jpn       Date:  1991-04

10.  Expression of a multidrug resistance gene in human cancers.

Authors:  L J Goldstein; H Galski; A Fojo; M Willingham; S L Lai; A Gazdar; R Pirker; A Green; W Crist; G M Brodeur
Journal:  J Natl Cancer Inst       Date:  1989-01-18       Impact factor: 13.506

View more
  4 in total

1.  Heterogeneity of chemosensitivity in six clonal cell lines derived from a spontaneous murine astrocytoma and its relationship to genotypic and phenotypic characteristics.

Authors:  R Bradford; H Koppel; G J Pilkington; D G Thomas; J L Darling
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

2.  Clinical significance of large tenascin-C spliced variant as a potential biomarker for colorectal cancer.

Authors:  Akihiko Takeda; Yoshihide Otani; Hiroyoshi Iseki; Hideki Takeuchi; Kimiyasu Aikawa; Satoru Tabuchi; Nozomi Shinozuka; Toshiaki Saeki; Yasushi Okazaki; Isamu Koyama
Journal:  World J Surg       Date:  2007-02       Impact factor: 3.352

3.  Expression Changes and Impact of the Extracellular Matrix on Etoposide Resistant Human Retinoblastoma Cell Lines.

Authors:  Jacqueline Reinhard; Natalie Wagner; Miriam M Krämer; Marvin Jarocki; Stephanie C Joachim; H Burkhard Dick; Andreas Faissner; Vinodh Kakkassery
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

4.  The Significance of Serum S100A9 and TNC Levels as Biomarkers in Colorectal Cancer.

Authors:  Minze Zhou; Maoyu Li; Xujun Liang; Ye Zhang; Huichao Huang; Yilu Feng; Guoqiang Wang; Ting Liu; Zhuchu Chen; Haiping Pei; Yongheng Chen
Journal:  J Cancer       Date:  2019-08-29       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.